Latest Articles

Publication Date
All News Scientific
Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - BioSpace

Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting BioSpace

Published: May 23, 2025, 5:55 a.m.
Read Full Article
Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting - The Manila Times

Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting The Manila Times

Published: May 23, 2025, 12:24 a.m.
Read Full Article
Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - The Manila Times

Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting The Manila Times

Published: May 22, 2025, 9:19 p.m.
Read Full Article
Genmab to Highlight New Data Evaluating Late-Stage Oncology - GlobeNewswire

Genmab to Highlight New Data Evaluating Late-Stage Oncology GlobeNewswire

Published: May 22, 2025, 9:06 p.m.
Read Full Article
Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - Business Wire

Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting Business Wire

Published: May 22, 2025, 9:05 p.m.
Read Full Article
Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - FinancialContent

Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting FinancialContent

Published: May 22, 2025, 9:05 p.m.
Read Full Article
Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025 - Morningstar

Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025 Morningstar

Published: May 20, 2025, 12:08 p.m.
Read Full Article
Cadonilimab-Lenvatinib Combo Exhibits Activity in Advanced Endometrial Cancer - Oncology Nurse Advisor

Cadonilimab-Lenvatinib Combo Exhibits Activity in Advanced Endometrial Cancer Oncology Nurse Advisor

Published: April 21, 2025, 4 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!